BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » Monthly Archive for: 'February 21st, 2012'
Biocrine’s home page launched

Biocrine’s home page launched

Posted in: Company news|February 21, 2012

www.biocrine.se is live Our company web site www.biocrine.com is now launched. We will be looking forward to your feedback on info@biocrine.se. With best regards, The Biocrine team

Read more »
Unique innervation pattern of the human islets of Langerhans

Unique innervation pattern of the human islets of Langerhans

Posted in: Publication|February 21, 2012

The unique innervation pattern of the human islets of Langerhans has been described in two articles in the Nature Medicine and Cell Metabolism. These results will have major implications for future development of novel drugs for the treatment of diabetes. Hormone release by the endocrine pancreas is regulated by the autonomic, non-voluntarily, nervous system, consisting …

Read more »
Biocrine’s CEO featured at IVA’s annual meeting

Biocrine’s CEO featured at IVA’s annual meeting

Posted in: Company news, Society|February 21, 2012

        On the 28th of October 2011, Biocrine was featured as one of the prominent life science companies on the 92nd annual meeting of IVA. In an interview for IVA, Biocrine’s CEO Per-Olof Berggren talked about the main focus of the research; understanding of how a healthy insulin producing beta cell works, …

Read more »
Lower levels of apolipoprotein CIII reduce risk of getting type 1 diabetes

Lower levels of apolipoprotein CIII reduce risk of getting type 1 diabetes

Posted in: Publication|February 21, 2012

        A promising way to delay onset of type 1 diabetes is to reduce the concentration of apolipoprotein CIII (apoCIII) in blood. This discovery is presented in a newly published article in PNAS from June 2011. It took twice as long for the rats that have undergone therapy reducing apoCIII to develop …

Read more »
InSight for observing how immune system reacts to the islets of Langerhans

InSight for observing how immune system reacts to the islets of Langerhans

Posted in: Publication|February 21, 2012

        New success of the InSight* technology is now presented in an article in PNAS from July 18th, 2011. Using this unique technology in a mouse model, reactions of the immune system to implanted islets of Langerhans were for the first time observed in a living organism. Following an allogeneic transplantation of beta …

Read more »
Donor Islet Endothelial Cells

Donor Islet Endothelial Cells

Posted in: Publication|February 21, 2012

Endothelial cells lining surfaces of donor islets promote a faster initial blood vessel formation after transplantation. The results are published in Diabetes in October 2011. Patients with type 1 diabetes lack insulin, as the majority of the pancreatic beta cells producing this vital hormone have been destroyed. Transplanting donor islets of Langerhans, built up primarily …

Read more »
Transplantation into the eye can cure diabetes

Transplantation into the eye can cure diabetes

Posted in: Publication|February 21, 2012

        Insulin shots for patients with type 1 diabetes can become history. A novel site to transplant donor islet of Langerhans may give a chance to cure patients’ own failing insulin production. When transplanted into the anterior chamber of the eye of a diabetic monkey, pancreatic islets survive and produce insulin, reducing …

Read more »

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications February 6, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved